Craig Roberts
Net worth: 9 487 $ as of 30/06/2026
Net worth: 9 487 $ as of 30/06/2026
Mr. Craig P.
Roberts is a Director & Chief Technology Officer at Sigyn Therapeutics, Inc. He is on the Board of Directors at Sigyn Therapeutics, Inc. Mr. Roberts was previously employed as a Director & Chief Technology Officer by HemoLife Medical, Inc. and a Chief Technology Officer by Sigyn Therapeutics, Inc. /Old/.
He also served on the board at Reign Resources Corp.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SIGYN THERAPEUTICS, INC. 15.97% | 11/04/2025 | 256,400 ( 15.97% ) | 9 487 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| SIGYN THERAPEUTICS, INC. | Founder | 19/10/2019 |
| Companies | Position | End |
|---|---|---|
| SIGYN THERAPEUTICS, INC. | Director/Board Member | - |
HemoLife Medical, Inc.
HemoLife Medical, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Founder | - |
Sigyn Therapeutics, Inc. /Old/
Sigyn Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a therapeutic company that develops blood purification technology | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
HemoLife Medical, Inc.
HemoLife Medical, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Reign Resources Corp.
Reign Resources Corp. Wholesale DistributorsDistribution Services Engages in processing rough sapphires and gem cutting, and designing, manufacturing and selling jewelry | Distribution Services |
Sigyn Therapeutics, Inc. /Old/
Sigyn Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a therapeutic company that develops blood purification technology | Health Technology |
Sigyn Therapeutics, Inc.
Sigyn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions